• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Introduction to 1-(1,2-oxazol-5-yl)methanamine hydrochloride (CAS No. 440099-32-1)

1-(1,2-oxazol-5-yl)methanamine hydrochloride, identified by its Chemical Abstracts Service (CAS) number 440099-32-1, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the oxazole derivatives, a class of heterocyclic compounds that have garnered considerable attention due to their diverse biological activities and structural versatility. The presence of the oxazole ring, a five-membered aromatic ring containing one oxygen atom, contributes to the unique electronic and steric properties of this molecule, making it a valuable scaffold for drug discovery and development.

The hydrochloride salt form of 1-(1,2-oxazol-5-yl)methanamine enhances its solubility in aqueous media, which is a critical factor for pharmaceutical applications. This solubility profile facilitates its use in various formulation processes and biological assays. The amine functional group at the methanamine moiety provides a site for further chemical modifications, enabling the synthesis of more complex derivatives with tailored biological properties.

In recent years, oxazole derivatives have been extensively studied for their potential therapeutic effects. These compounds exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The oxazole core is particularly notable for its ability to interact with biological targets such as enzymes and receptors, making it an attractive motif for medicinal chemists. The specific substitution pattern in 1-(1,2-oxazol-5-yl)methanamine hydrochloride may influence its binding affinity and selectivity towards these targets.

One of the most compelling aspects of this compound is its role in the development of novel therapeutic agents. Researchers have been exploring its potential as a precursor for more complex molecules that can modulate specific biological pathways. For instance, studies have shown that oxazole derivatives can interfere with metabolic pathways involved in cancer progression by inhibiting key enzymes or disrupting signaling cascades. The amine group in 1-(1,2-oxazol-5-yl)methanamine hydrochloride serves as a versatile handle for further functionalization, allowing chemists to design molecules with enhanced potency and reduced toxicity.

The synthesis of 1-(1,2-oxazol-5-yl)methanamine hydrochloride involves multi-step organic transformations that highlight the ingenuity of modern synthetic chemistry. The construction of the oxazole ring typically requires cyclocondensation reactions between appropriate precursors under controlled conditions. Subsequent functionalization steps introduce the methanamine group and its subsequent conversion to the hydrochloride salt. These synthetic routes underscore the importance of robust methodologies in producing complex molecules like this one.

Recent advances in computational chemistry have also played a pivotal role in understanding the behavior of 1-(1,2-oxazol-5-yl)methanamine hydrochloride. Molecular modeling techniques allow researchers to predict how this compound interacts with biological targets at the atomic level. These predictions are crucial for designing experiments and optimizing synthetic routes before conducting expensive wet-lab studies. Additionally, computational methods can help identify potential side effects or toxicities associated with the compound.

The pharmacokinetic properties of 1-(1,2-oxazol-5-yl)methanamine hydrochloride are another area of active investigation. Understanding how a compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for determining its clinical efficacy and safety profile. Studies have begun to explore how modifications to the oxazole ring or other parts of the molecule can influence these properties. For example, certain substituents may enhance oral bioavailability or prolong systemic exposure.

In clinical settings, 1-(1,2-oxazol-5-yl)methanamine hydrochloride may be used as an intermediate in drug development pipelines or as a lead compound itself. Its structural features make it amenable to further derivatization into molecules with improved pharmacological profiles. Researchers are particularly interested in how variations around the oxazole core can modulate activity against specific disease targets while minimizing off-target effects.

The regulatory landscape for new pharmaceutical compounds also impacts the development process of 1-(1,2-oxazol-5-yl)methanamine hydrochloride. Compliance with guidelines set forth by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is essential for ensuring safety and efficacy before human use. This involves rigorous testing across multiple phases of clinical trials to demonstrate both therapeutic benefit and acceptable risk profiles.

Ethical considerations are paramount when developing new drugs like those derived from 1-(1,2-oxazol-5-yl)methanamine hydrochloride. Involving diverse patient populations in clinical trials ensures that benefits are equitably distributed across different demographics. Additionally, sustainable synthetic methods that minimize environmental impact are increasingly becoming part of green chemistry initiatives within pharmaceutical companies.

The future directions for research on 1-(1,2-oxazol-5-yl)methanamine hydrochloride include exploring new synthetic pathways that improve efficiency and scalability while reducing waste generation. Collaborative efforts between academia and industry will be crucial in translating laboratory discoveries into viable therapeutic agents suitable for clinical use.

• 1187930-08-0(1-Isoxazol-5-yl-ethylamine Hydrochloride)
• 5765-44-6(5-methyl-1,2-oxazole)
• 173850-38-9(5-Isoxazolemethanamine,N,N-dimethyl-)
• 497947-78-1(5-(azidomethyl)-1,2-oxazole)
• 952195-14-1(ethyl-isoxazol-5-ylmethyl-amine)
• 2172852-93-4(1-(Isoxazol-5-yl)ethanaminedihydrochloride)
• 70183-89-0((3-methylisoxazol-5-yl)methylamine)
• 1187927-44-1(Isoxazol-5-ylmethyl-methyl-amine hydrochloride)
• 154016-55-4((3-methylisoxazol-5-yl)methylamine)
• 401647-20-9(Isoxazol-5-ylmethyl-methyl-amine)